Aurinia (AUPH) Up on Paving the Way for a Potential Buyout

Aurinia (AUPH) surges as management decides to explore strategic business options, including potential sale or a merger.

Related Keywords

George Milne ,Joseph Hagan ,Novartis ,Zacks Investment Research ,Aurinia Pharmaceuticals Inc Price ,Aurinia Pharmaceuticals Inc ,Image Source ,Zacks Investment ,Pharmaceuticals Inc Price ,Pharmaceuticals Inc ,Zacks Rank ,Strong Buy ,Zacks Consensus Estimate ,Akero Therapeutics ,Omega Therapeutics ,Auph ,Strategic Alternatives ,Aurinia ,Product Revenue ,